These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27631819)

  • 1. Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.
    Brown A; Halliday JS; Swadling L; Madden RG; Bendall R; Hunter JG; Maggs J; Simmonds P; Smith DB; Vine L; McLaughlin C; Collier J; Bonsall D; Jeffery K; Dunachie S; Klenerman P; Izopet J; Kamar N; Dalton HR; Barnes E
    Hepatology; 2016 Dec; 64(6):1934-1950. PubMed ID: 27631819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E.
    Al-Ayoubi J; Behrendt P; Bremer B; Suneetha PV; Gisa A; Rinker F; Manns MP; Cornberg M; Wedemeyer H; Kraft ARM
    Liver Int; 2018 Feb; 38(2):266-277. PubMed ID: 28718943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector T cells immune reactivity among patients with acute hepatitis E.
    Husain MM; Aggarwal R; Kumar D; Jameel S; Naik S
    J Viral Hepat; 2011 Oct; 18(10):e603-8. PubMed ID: 21914082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.
    Aggarwal R; Shukla R; Jameel S; Agrawal S; Puri P; Gupta VK; Patil AP; Naik S
    J Viral Hepat; 2007 Apr; 14(4):283-92. PubMed ID: 17381721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection.
    Gisa A; Suneetha PV; Behrendt P; Pischke S; Bremer B; Falk CS; Manns MP; Cornberg M; Wedemeyer H; Kraft AR
    J Viral Hepat; 2016 Apr; 23(4):305-15. PubMed ID: 26852892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HEV seroprevalence in patients with autoimmune hepatitis.
    Pischke S; Gisa A; Suneetha PV; Wiegand SB; Taubert R; Schlue J; Wursthorn K; Bantel H; Raupach R; Bremer B; Zacher BJ; Schmidt RE; Manns MP; Rifai K; Witte T; Wedemeyer H
    PLoS One; 2014; 9(1):e85330. PubMed ID: 24465537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients.
    Abravanel F; Barragué H; Dörr G; Sauné K; Péron JM; Alric L; Kamar N; Izopet J; Champagne E
    J Infect; 2016 Jun; 72(6):723-730. PubMed ID: 26947133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
    Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
    J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology and Host Response to HEV.
    Zhou Y
    Adv Exp Med Biol; 2016; 948():113-141. PubMed ID: 27738982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.
    Shata MT; Barrett A; Shire NJ; Abdelwahab SF; Sobhy M; Daef E; El-Kamary SS; Hashem M; Engle RE; Purcell RH; Emerson SU; Strickland GT; Sherman KE
    J Immunol Methods; 2007 Dec; 328(1-2):152-61. PubMed ID: 17905301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection.
    Suneetha PV; Pischke S; Schlaphoff V; Grabowski J; Fytili P; Gronert A; Bremer B; Markova A; Jaroszewicz J; Bara C; Manns MP; Cornberg M; Wedemeyer H
    Hepatology; 2012 Mar; 55(3):695-708. PubMed ID: 22006345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody and Memory B Cell Responses in Hepatitis E Recovered Individuals, 1-30 Years Post Hepatitis E Virus Infection.
    Kulkarni SP; Sharma M; Tripathy AS
    Sci Rep; 2019 Mar; 9(1):4090. PubMed ID: 30858463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection.
    Tripathy AS; Das R; Rathod SB; Arankalle VA
    PLoS One; 2012; 7(2):e31822. PubMed ID: 22384080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein.
    Srivastava R; Aggarwal R; Jameel S; Puri P; Gupta VK; Ramesh VS; Bhatia S; Naik S
    Viral Immunol; 2007; 20(1):56-65. PubMed ID: 17425421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection.
    Kemming J; Gundlach S; Panning M; Huzly D; Huang J; Lütgehetmann M; Pischke S; Schulze Zur Wiesch J; Emmerich F; Llewellyn-Lacey S; Price DA; Tanriver Y; Warnatz K; Boettler T; Thimme R; Hofmann M; Fischer N; Neumann-Haefelin C
    J Hepatol; 2022 Oct; 77(4):978-990. PubMed ID: 35636577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-λ3 as a host immune response in acute hepatitis E virus infection.
    Murata K; Kang JH; Nagashima S; Matsui T; Karino Y; Yamamoto Y; Atarashi T; Oohara M; Uebayashi M; Sakata H; Matsubayashi K; Takahashi K; Arai M; Mishiro S; Sugiyama M; Mizokami M; Okamoto H
    Cytokine; 2020 Jan; 125():154816. PubMed ID: 31465972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model.
    Khateri M; Abdoli A; Motevalli F; Fotouhi F; Bolhassani A; Arashkia A; Jazaeri EO; Shahbazi S; Mehrbod P; Naziri H; Aghasadeghi MR
    IUBMB Life; 2018 Mar; 70(3):207-214. PubMed ID: 29369472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
    Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.